Inventor · disambiguated record
John Richard Morphy
Also filed as: MORPHY JOHN R · MORPHY JOHN RICHARD
16 granted patents·4 pending applications·77 citations·filing 1991–2025
90Inventor score
Top patents by PatentIndex Score
20 records- 0183US7807686B22-(4-oxo-4H-quinazolin-3-yl)acetamides and their use as vasopressin V3 antagonistsORGANON NV·Filed 2006·Granted Oct 5, 2010·11 cites·15 claims
- 0276US9598431B1Compounds useful for inhibiting ROR-gamma-tLILLY CO ELI·Filed 2016·Granted Mar 21, 2017·2 cites·8 claims
- 0371US10603320B2Compounds useful for inhibiting ROR-gamma-tLILLY CO ELI·Filed 2018·Granted Mar 31, 2020·1 cites·15 claims
- 0469US7960365B2Compounds with medicinal effects due to interaction with the glucocorticoid receptorORGANON NV·Filed 2006·Granted Jun 14, 2011·2 cites·6 claims
- 0567US5569665APeptidyl derivatives and their use as metalloproteinases inhibitorsCELLTECH LTD·Filed 1993·Granted Oct 29, 1996·21 cites·8 claims
- 0667US2024269113A13-(2-(DIMETHYLAMINO)ETHYL)-1H-INDOL-4-yl DERIVATIVESCOMPASS PATHFINDER LTD·Filed 2024·Application pending·0 cites
- 0767US2025066394A13-(2-(DIMETHYLAMINO)ETHYL)-1H-INDOL-4-yl DERIVATIVESCOMPASS PATHFINDER LTD·Filed 2024·Application pending·0 cites
- 0866US5300501APeptidyl derivativesCELLTECH LTD·Filed 1991·Granted Apr 5, 1994·20 cites·12 claims
- 0966US2025066300A13-(2-(DIMETHYLAMINO)ETHYL)-1H-INDOL-4-yl OLIGOMERIC DERIVATIVESCOMPASS PATHFINDER LTD·Filed 2024·Application pending·0 cites
- 1056US11453673B2Substituted [1,2,4]triazolo[4,3-a]pyrazines as phosphodiesterase inhibitorsLILLY CO ELI·Filed 2019·Granted Sep 27, 2022·0 cites·12 claims
- 1156US7126027B2N-[(1-dimethylaminocycloalkyl)methyl]benzamide derivativesAKZO NOBEL NV·Filed 2002·Granted Oct 24, 2006·2 cites·9 claims
- 1254US5714491APeptidyl derivatives as metalloproteinase inhibitorsCELLTECH THERAPEUTICS LTD·Filed 1994·Granted Feb 3, 1998·11 cites·9 claims
- 1352US11180503B2[1,2,4]Triazolo[4,3-A]pyrazin-6(5H)-one derivativesLILLY CO ELI·Filed 2018·Granted Nov 23, 2021·0 cites·12 claims
- 1449US2025352514A1Salt forms of bis(3-(2-(dimethylamino)ethyl)-1 h-indol-4-yl) 3,3'¬oxydipropionateCOMPASS PATHFINDER LTD·Filed 2025·Application pending·0 cites
- 1545US7906504B22-(1-oxo-1H-isoquinolin-2-yl)acetamide derivativesORGANON NV·Filed 2007·Granted Mar 15, 2011·0 cites·11 claims
- 1643US5530128AN-sulphonylamino derivatives of dipetide compounds as metalloproteinase inhibitorsCELLTECH THERAPEUTICS LTD·Filed 1993·Granted Jun 25, 1996·5 cites·10 claims
- 1741US7893088B26-substituted isoquinoline derivativesORGANON NV·Filed 2007·Granted Feb 22, 2011·0 cites·12 claims
- 1840US11008336B2Compounds useful for inhibiting RORγtLILLY CO ELI·Filed 2018·Granted May 18, 2021·0 cites·16 claims
- 1933US7084154B22-(aminomethyl) arylamide analgesicsPHARMACOPEIA DRUG DISCLOVERY I·Filed 2003·Granted Aug 1, 2006·0 cites·14 claims
- 2032US5889058APeptidyl derivativesCELLTECH LTD·Filed 1994·Granted Mar 30, 1999·2 cites·4 claims
Join the waitlist — get patent alerts
Get an alert when John Richard Morphy files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →